McPherson E, Crawford B, Kenny S, Dipane M, Salarkia S, Stavrakis A
Arthroplast Today. 2024; 25:101302.
PMID: 38304243
PMC: 10830497.
DOI: 10.1016/j.artd.2023.101302.
Boot W, Foster A, Guillaume O, Eglin D, Schmid T, DEste M
Front Cell Infect Microbiol. 2022; 12:826392.
PMID: 35573772
PMC: 9093643.
DOI: 10.3389/fcimb.2022.826392.
Heffernan J, Overstreet D, Vernon B, McLemore R, Nagy T, Moore R
J Biomed Mater Res B Appl Biomater. 2021; 110(1):103-114.
PMID: 34128323
PMC: 8608705.
DOI: 10.1002/jbm.b.34894.
Cara A, Ballet M, Hemery C, Ferry T, Laurent F, Josse J
Front Med (Lausanne). 2021; 7:576231.
PMID: 33553196
PMC: 7856860.
DOI: 10.3389/fmed.2020.576231.
Lee Y, Farhan S, Pendi A, Cunningham T, Kiester P, Hahn P
Global Spine J. 2018; 8(8):816-820.
PMID: 30560033
PMC: 6293436.
DOI: 10.1177/2192568218776609.
Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro.
Harris M, Ahmed H, Pace L, Minter J, Neel M, Jennings J
J Funct Biomater. 2018; 9(4).
PMID: 30248929
PMC: 6306754.
DOI: 10.3390/jfb9040055.
Treatment of chronic orthopaedic infection.
Winkler H
EFORT Open Rev. 2017; 2(5):110-116.
PMID: 28630748
PMC: 5467682.
DOI: 10.1302/2058-5241.2.160063.
Allograft Bone as Antibiotic Carrier.
Winkler H, Haiden P
J Bone Jt Infect. 2017; 2(1):52-62.
PMID: 28529864
PMC: 5423575.
DOI: 10.7150/jbji.17466.
Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
Castaneda P, McLaren A, Tavaziva G, Overstreet D
Clin Orthop Relat Res. 2016; 474(7):1659-64.
PMID: 26797908
PMC: 4887352.
DOI: 10.1007/s11999-016-4700-z.
Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue.
Oliver R, Lovric V, Yu Y, Christou C, Aiken S, Cooper J
PLoS One. 2015; 10(8):e0136514.
PMID: 26305692
PMC: 4549236.
DOI: 10.1371/journal.pone.0136514.
Antibiotic-loaded cement in orthopedic surgery: a review.
Bistolfi A, Massazza G, Verne E, Masse A, Deledda D, Ferraris S
ISRN Orthop. 2014; 2011:290851.
PMID: 24977058
PMC: 4063209.
DOI: 10.5402/2011/290851.
Industrially prefabricated cement spacers: do vancomycin- and gentamicin-impregnated spacers offer any advantage?.
Corona P, Barro V, Mendez M, Caceres E, Flores X
Clin Orthop Relat Res. 2013; 472(3):923-32.
PMID: 24142302
PMC: 3916603.
DOI: 10.1007/s11999-013-3342-7.
Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.
Winkler H
Int J Med Sci. 2009; 6(5):247-52.
PMID: 19834590
PMC: 2755120.
DOI: 10.7150/ijms.6.247.
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
Moise-Broder P, Forrest A, Birmingham M, Schentag J
Clin Pharmacokinet. 2004; 43(13):925-42.
PMID: 15509186
DOI: 10.2165/00003088-200443130-00005.
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Lee D, Chun H, Yim D, Choi S, Choi J, Yoo J
Antimicrob Agents Chemother. 2003; 47(12):3768-73.
PMID: 14638480
PMC: 296184.
DOI: 10.1128/AAC.47.12.3768-3773.2003.
In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
Pestel-Caron M, Lemeland J, Caron F
Antimicrob Agents Chemother. 2000; 44(11):3055-60.
PMID: 11036022
PMC: 101602.
DOI: 10.1128/AAC.44.11.3055-3060.2000.
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Houlihan H, Mercier R, Rybak M
Antimicrob Agents Chemother. 1997; 41(11):2497-501.
PMID: 9371356
PMC: 164151.
DOI: 10.1128/AAC.41.11.2497.
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.
Chambers H
Clin Microbiol Rev. 1997; 10(4):781-91.
PMID: 9336672
PMC: 172944.
DOI: 10.1128/CMR.10.4.781.
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
Mercier R, Houlihan H, Rybak M
Antimicrob Agents Chemother. 1997; 41(6):1307-12.
PMID: 9174189
PMC: 163905.
DOI: 10.1128/AAC.41.6.1307.
Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus.
Mulazimoglu L, Drenning S, Muder R
Antimicrob Agents Chemother. 1996; 40(6):1534-5.
PMID: 8726033
PMC: 163363.
DOI: 10.1128/AAC.40.6.1534.